Abstract: A set of flanges, an installation including the set of flange and a method for providing the installation are disclosed. The set of flanges includes a first annular flange with a first front side and a second annular flange with a second front side. Each flange includes a plurality of through holes for mounting the flanges with the first side facing the second side. The first and the second sides are shaped such that the annular toe surface section of the first front side is adapted to provide an annular toe contact region with the annular toe surface section of the second front side and the annular heel surface section of the first front surface is adapted to provide annular heel contact region with the annular heel surface section of the second front side whereby an intermediate annular gap is provided between the annular toe contact region and the annular heel contact region.

Abstract: The present invention relates to functional binding fragments comprising the minimal binding fragments of VAR2CSA, to antibodies against such binding fragments of VAR2CSA, nucleic acids encoding such fragments of VAR2CSA as well as methods for their production. The invention further relates to conjugates and fusion proteins of VAR2CSA polypeptides including the minimal binding fragments and their use, in particular in the treatment of conditions associated with expression of chondroitin sulfate A (CSA), such as an inappropriate expression of chondroitin sulfate A (CSA).

Abstract: The present invention relates to functional binding fragments comprising the minimal binding fragments of VAR2CSA, to antibodies against such binding fragments of VAR2CSA, nucleic acids encoding such fragments of VAR2CSA as well as methods for their production. The invention further relates to conjugates and fusion proteins of VAR2CSA polypeptides including the minimal binding fragments and their use, in particular in the treatment of conditions associated with expression of chondroitin sulfate A (CSA), such as an inappropriate expression of chondroitin sulfate A (CSA).

Abstract: The present invention relates to functional binding fragments comprising the minimal binding fragments of VAR2CSA, to antibodies against such binding fragments of VAR2CSA, nucleic acids encoding such fragments of VAR2CSA as well as methods for their production. The invention further relates to conjugates and fusion proteins of VAR2CSA polypeptides including the minimal binding fragments and their use, in particular in the treatment of conditions associated with expression of chondroitin sulfate A (CSA), such as an inappropriate expression of chondroitin sulfate A (CSA).

Abstract: The present invention relates to functional binding fragments comprising the minimal binding fragments of VAR2CSA, to antibodies against such binding fragments of VAR2CSA, nucleic acids encoding such fragments of VAR2CSA as well as methods for their production. The invention further relates to conjugates and fusion proteins of VAR2CSA polypeptides including the minimal binding fragments and their use, in particular in the treatment of conditions associated with expression of chondroitin sulfate A (CSA), such as an inappropriate expression of chondroitin sulfate A (CSA).

Abstract: The present invention relates to functional binding fragments comprising the minimal binding fragments of VAR2CSA, to antibodies against such binding fragments of VAR2CSA, nucleic acids encoding such fragments of VAR2CSA as well as methods for their production. The invention further relates to conjugates and fusion proteins of VAR2CSA polypeptides including the minimal binding fragments and their use, in particular in the treatment of conditions associated with expression of chondroitin sulfate A (CSA), such as an inappropriate expression of chondroitin sulfate A (CSA).

Abstract: The present invention relates to functional binding fragments comprising the minimal binding fragments of VAR2CSA, to antibodies against such binding fragments of VAR2CSA, nucleic acids encoding such fragments of VAR2CSA as well as methods for their production. The invention further relates to conjugates and fusion proteins of VAR2CSA polypeptides including the minimal binding fragments and their use, in particular in the treatment of conditions associated with expression of chondroitin sulfate A (CSA), such as an inappropriate expression of chondroitin sulfate A (CSA).

Abstract: The present invention relates to a scanning device and a method for scanning. The scanning device comprises a first frame (4) supporting a first deflector (6), and a second frame (8) supporting a second deflector (10). The first frame is arranged for rotation around a first axis (12), and the second frame is arranged for rotation around a second axis (14). The first frame is rotatably connected to a base (38) for rotation around the first axis and the second frame is arranged for rotation around the first axis. The method for scanning comprises rotating the first frame around the first axis according to a first selected value, and rotating the second frame around the second axis according to a second selected value.

Abstract: A computer implemented method of performing video surveillance on a computer system, wherein the computer system comprises a video and a display with a graphical user interface, the graphical user interface including a source window to view play back of the video, the surveillance method comprising: determining an area of interest of a frame of the video based upon a selection of the area of interest within the source window, and generating a plurality of windows within the graphical user interface, each of the windows displaying the area of interest of the frame of the video at a point in time, wherein the graphical user interface includes controls to manipulate the playback of the video from a point in time relative to each displayed portion.

Abstract: Presented and claimed is a portable device for communication, in particular a mobile telephone, in which emergency operation with transmitting and receiving is possible even with empty rechargeable battery. For this purpose, in addition to a main rechargeable battery (14), which is provided and designed for normal operation and is charged by a separate charging device at a power outlet, the device (10) has an emergency rechargeable battery (16), which is charged by an integrated electromechanical generator (22). This generator, which supplies electricity during movement of the device, is an unbalance rotation generator (22), known per se, or a linear generator. During emergency operation, the main battery (14) is not connected to the electronics (12) of the device, and the limited functions of the device necessary for the emergency operation are supplied with current by the emergency rechargeable battery (16). In addition, a switch (32), able to be actuated from outside or automatically, is built in.

Abstract: The present invention relates to a scanning device and a method for scanning. The scanning device comprises a first frame (4) supporting a first deflector (6), and a second frame (8) supporting a second deflector (10). The first frame is arranged for rotation around a first axis (12), and the second frame is arranged for rotation around a second axis (14). The first frame is rotatably connected to a base (38) for rotation around the first axis and the second frame is arranged for rotation around the first axis. The method for scanning comprises rotating the first frame around the first axis according to a first selected value, and rotating the second frame around the second axis according to a second selected value.

Abstract: A digital baseband processor is provided for concurrent operation with different wireless systems. The digital baseband processor includes a digital signal processor for executing digital signal processor instructions, a microcontroller for executing microcontroller instructions, and a timing and event processor controlled by the digital signal processor and the microcontroller for executing timing-sensitive instructions. The timing and event processor includes a plurality of instruction sequencers for executing timing-sensitive instruction threads and a time base generator for generating timing signals for initiating execution of the instruction threads on each of the plurality of instruction sequencers.

Abstract: Embodiments of the present invention pertain to implementation of textual names as the actual identifiers of elements of models. A structured system provided for constructing the textual names so as to be unique in a specific context. In one embodiment, namespaces are added to a name as a mechanism for ensuring uniqueness across multiple development sources. In one embodiment, upon deployment to a runtime environment, alternate names are assigned to support efficient processing.

Abstract: A digital baseband processor is provided for concurrent operation with different wireless systems. The digital baseband processor includes a digital signal processor for executing digital signal processor instructions, a microcontroller for executing microcontroller instructions, and a timing and event processor controlled by the digital signal processor and the microcontroller for executing timing-sensitive instructions. The timing and event processor includes a plurality of instruction sequencers for executing timing-sensitive instruction threads and a time base generator for generating timing signals for initiating execution of the instruction threads on each of the plurality of instruction sequencers.

Abstract: The present invention relates to nucleic acid molecules related to the PFD1235w/MAL7P1.1, PF11_0008, and PF13_0003 gene families as well as amino acid sequences encoded by such nucleic acid molecules with respect to their role in mediating adhesion of infected red blood cells to endothelial cells, which is characteristic for the pathogenesis of severe malaria (SM). Accordingly, the invention provides pharmaceutical compositions and vaccines, hereunder nucleotide-based vaccines comprising compounds that are related to VAR4, VAR5, and/or VAR6 polypeptides and PFD1235w/MAL7P1.1 PF11_0008, and/or PF13_0003 nucleic acid molecules. The invention further relates to the use of these compounds as medicaments and for the manufacture of compositions, such as immunogenic compositions. In addition, the invention relates to methods of treatment and prevention of severe malaria wherein these methods are based on the nucleic acid molecules and polypeptides of the invention.

Abstract: A computer implemented method of performing video surveillance on a computer system, wherein the computer system comprises a video and a display with a graphical user interface, the graphical user interface including a source window to view play back of the video, the surveillance method comprising: determining an area of interest of a frame of the video based upon a selection of the area of interest within the source window, and generating a plurality of windows within the graphical user interface, each of the windows displaying the area of interest of the frame of the video at a point in time, wherein the graphical user interface includes controls to manipulate the playback of the video from a point in time relative to each displayed portion.

Abstract: The customization system receives an application model that contains one or more elements stored in a database. The customization system receives a modification to an element of the application model. The customization system stores the modification to the element separately from the application model such that the application model is accessible in either a modified or unmodified state. Thus, multiple third parties can make changes to the same application model elements and business logic without causing conflicts with each other. In addition, updates and patches to the enterprise resource planning system can be applied with less likelihood that the customizations will be negatively affected.

Abstract: Embodiments of the present invention pertain to implementation of textual names as the actual identifiers of elements of models. A structured system provided for constructing the textual names so as to be unique in a specific context. In one embodiment, namespaces are added to a name as a mechanism for ensuring uniqueness across multiple development sources. In one embodiment, upon deployment to a runtime environment, alternate names are assigned to support efficient processing.